Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2000
08/16/2000CN1263087A Substituted alkyl tetramine derivative
08/16/2000CN1262948A Production method of gastric ulcer quickly-healing preparation
08/16/2000CN1262872A Symbiotic functional food
08/16/2000CN1055469C Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds, its preparing method and use
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103880 Amino acid sequence of mitogenic peptide; angiogenic agents especially for brain structures; wound healing agents for skin; for bone regeneration especially osteoporosis
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103747 Substituted imidazole derivative used as antagonists against muscarinic acetylcholine receptor on smooth muscles, treats dysuria
08/15/2000US6103739 Metalloproteinase inhibitors
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/15/2000US6103491 Methods and compositions for identifying morphogen analogs
08/15/2000US6103274 Pharmaceutical, orally applicable composition
08/15/2000US6103260 Antifoam oral solid dosage form preparations
08/15/2000US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof
08/15/2000CA2142861C Novel uses of il-4 and/or il-10, and antibodies against the same
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046235A1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046220A1 Triazole and tetrazole derivatives, and their therapeutic use
08/10/2000WO2000046219A1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
08/10/2000WO2000046214A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
08/10/2000WO2000046201A1 Benzamide derivatives and drugs containing the same
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000045815A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000WO2000045795A2 Topical sprays comprising a film forming composition
08/10/2000WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000WO2000028975A3 Improved chemical process and pharmaceutical formulation
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO1999006547A3 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361066A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/09/2000EP1025844A1 Remedy for hepatopathy
08/09/2000EP1025222A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function
08/09/2000EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity
08/09/2000EP1025109A1 Benzoxazine derivatives, preparation and application in therapy
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025095A1 Substituted chroman derivatives
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025083A1 Process for stereoselective synthesis of prostacyclin derivatives
08/09/2000EP1025079A1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
08/09/2000EP1024820A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
08/09/2000EP1024819A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
08/09/2000EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine
08/09/2000EP1024807A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment
08/09/2000EP1024805A1 Use of coumarin derivatives for the treatment of digestive tract disorders
08/09/2000EP1024804A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
08/09/2000EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
08/09/2000EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
08/09/2000CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives
08/09/2000CN1262680A 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
08/09/2000CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
08/09/2000CN1262674A Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262621A Gastrokinetic bicyclc benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262116A Chinese patent medicine for treating intractable and habitual constipation
08/09/2000CN1262114A 'Gannongjing' and its preparing process
08/09/2000CN1055234C Compound capsule for curing gastropathy and its preparing process
08/09/2000CN1055230C Medicine for treating stomach disease
08/09/2000CN1055223C Chinese medicine preparation for treatment of gastric ulcer, duodenal ulcer and gastritis
08/09/2000CN1055221C Medicine, medicinal liquor for curing gastropathy and preparing process thereof
08/09/2000CN1055219C Medicine for treatment of gastrosis and its preparing process
08/09/2000CN1055211C Antialcoholic liver-protecting preparation and its preparing method
08/09/2000CN1055209C Producing method for medicated ciagarette preventing and curing rotten teeth
08/08/2000US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100264 5H, 10H-imidazo [1,2-A] indeno [1,2-E] pyrazin-4-one derivatives, their preparation, their intermediates and medicaments containing them
08/08/2000US6100262 Morpholine ring nitrogen is substituted with a group haivng a carbonyl functionality; favourable gastrointestinal motility stimulating properties, they accelerate gastric emptying
08/08/2000US6100245 Orally administering simethicone, preferably with sulfasalazine
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099871 Mixture containing waxy grain starch thickener
08/08/2000US6099841 Include hgf receptor antibodies and fragments thereof; used to treat a pathological liver condition
08/08/2000CA2216165C Ndf peptides
08/08/2000CA2188227C Combination antiemetic therapy using nk-1 receptor antagonists
08/03/2000WO2000044788A1 Production of tetravalent antibodies
08/03/2000WO2000044770A1 Substituted phenethylamine derivatives
08/03/2000WO2000044761A2 Ketolide antibiotics
08/03/2000WO2000044753A1 Pirazino(aza)indole derivatives
08/03/2000WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000WO2000044745A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000WO2000044744A1 Potassium salt of ($i(s))-omeprazole
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044388A1 Modulation of immune response by ribavirin
1 ... 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 ... 1258